Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (12)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Bader, B.
Right arrow Articles by Drueckesl, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bader, B.
Right arrow Articles by Drueckesl, P.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A cGMP-Dependent Protein Kinase Assay for High Throughput Screening Based on Time-Resolved Fluorescence Resonance Energy Transfer

Benjamin Bader

Vasopharm BIOTECH GmbH, Wuerzburg, Germany, Institute of Clinical Biochemistry and Pathobiochemistry, Medical University Clinic, Wuerzburg, Germany

Elke Butt

Institute of Clinical Biochemistry and Pathobiochemistry, Medical University Clinic, Wuerzburg, Germany

Alois Palmetshofer

Institute of Clinical Biochemistry and Pathobiochemistry, Medical University Clinic, Wuerzburg, Germany

Ulrich Walter

Institute of Clinical Biochemistry and Pathobiochemistry, Medical University Clinic, Wuerzburg, Germany

Thomas Jarchau

Institute of Clinical Biochemistry and Pathobiochemistry, Medical University Clinic, Wuerzburg, Germany

Peter Drueckesl

Vasopharm BIOTECH GmbH, Wuerzburg, Germany, Institute of Clinical Biochemistry and Pathobiochemistry, Medical University Clinic, Wuerzburg, Germany, KTB Tumorforschungs GmbH, Klinik fur Tumorbiologie, Freiburg, Germany

Activation of cyclic GMP-dependent protein kinase (cGK) is an important event in the regulation of blood pressure and platelet function. Upstream signals are the generation of nitric oxide (NO) by NO syntheses and the subsequent rise in cyclic GMP levels mediated by NO-dependent guanylyl cyclases (GCs). The identification of new cGK activators by high throughput sreening (HTS) may lead to the development of a novel class of therapeutics for the treatment of cardiovascular diseases. Therefore, a homogeneous, nonradioactive assay for cGK activity was developed using a biotinylated peptide derived from vasodilator-stimulated phosphoprotein (VASP), a well-characterized natural cGK substrate. The phosphorylated peptide could be detected by a VASP-specific monoclonal phosphoserine antibody and a fluorescent detection system consisting of a europium-labeled secondary antibody and allophycocyanin (APC)-labeled streptavidin. Fluorescence resonance energy transfer (FRET) from europium to APC was detected in a time-resolved fashion (TR-FRET). Activation and inhibition constants for known substances determined by this new fluorescence-based assay correlated well with published results obtained by conventional radioactive cGK activity assays. The assay proved to be sensitive, robust, highly specific for cGK, and suitable for HTS in 96- and 384-well formats. This assay is applicable to purified enzymes as well as to complex samples such as human platelet extracts.

Journal of Biomolecular Screening, Vol. 6, No. 4, 255-264 (2001)
DOI: 10.1177/108705710100600407
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Biol. Reprod.Home page
J.J. Peluso and A. Pappalardo
Progesterone Regulates Granulosa Cell Viability Through a Protein Kinase G-Dependent Mechanism That May Involve 14-3-3{sigma}
Biol Reprod, December 1, 2004; 71(6): 1870 - 1878.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
M. Newman and S. Josiah
Utilization of Fluorescence Polarization and Time Resolved Fluorescence Resonance Energy Transfer Assay Formats for SAR Studies: Src Kinase as a Model System
J Biomol Screen, September 1, 2004; 9(6): 525 - 532.
[Abstract] [PDF]

Home page
 J Biomol ScreenHome page
T. C. Turek-Etienne, M. Lei, J. S. Terracciano, E. F. Langsdorf, R. W. Bryant, R. F. Hart, and A. C. Horan
Use of Red-Shifted Dyes in a Fluorescence Polarization AKT Kinase Assay for Detection of Biological Activity in Natural Product Extracts
J Biomol Screen, February 1, 2004; 9(1): 52 - 61.
[Abstract] [PDF]

Home page
 CirculationHome page
T. Munzel, R. Feil, A. Mulsch, S. M. Lohmann, F. Hofmann, and U. Walter
Physiology and Pathophysiology of Vascular Signaling Controlled by Cyclic Guanosine 3',5'-Cyclic Monophosphate-Dependent Protein Kinase
Circulation, November 4, 2003; 108(18): 2172 - 2183.
[Full Text] [PDF]

Home page
 J Biomol ScreenHome page
D. J. Moshinsky, L. Ruslim, R. A. Blake, and F. Tang
A Widely Applicable, High-Throughput TR-FRET Assay for the Measurement of Kinase Autophosphorylation: VEGFR-2 as a Prototype
J Biomol Screen, August 1, 2003; 8(4): 447 - 452.
[Abstract] [PDF]

Home page
 J Biomol ScreenHome page
R. Mallari, E. Swearingen, W. Liu, A. Ow, S. W. Young, and S.-G. Huang
A Generic High-Throughput Screening Assay for Kinases: Protein Kinase A as an Example
J Biomol Screen, April 1, 2003; 8(2): 198 - 204.
[Abstract] [PDF]